L-5103 Lepetit
Categoria
L-5103 Lepetit Marchi, L-5103 Lepetit Analoghi
L-5103 Lepetit Marchi miscela
L-5103 Lepetit Formula chimica
L-5103 Lepetit RX link
L-5103 Lepetit FDA foglio
L-5103 Lepetit DMS (foglio di materiale di sicurezza)
L-5103 Lepetit Sintesi di riferimento
L-5103 Lepetit Peso molecolare
L-5103 Lepetit Temperatura di fusione
L-5103 Lepetit H2O Solubilita
L-5103 Lepetit Stato
L-5103 Lepetit LogP
L-5103 Lepetit Forme di dosaggio
L-5103 Lepetit Indicazione
L-5103 Lepetit Farmacologia
L-5103 Lepetit Assorbimento
L-5103 Lepetit Tossicita
L-5103 Lepetit Informazioni paziente
The patient should be told that rifampin may produce a reddish coloration of the urine, sweat, sputum, and tears, and the patient should be forewarned of this. Soft contact lenses may be permanently stained. The patients should be advised that the reliability of oral or other systemic hormonal contraceptives may be affected; consideration should be given to using alternative contraceptive measures. Patients should be instructed to take rifampin either 1 hour before or 2 hours after a meal with a full glass of water. Patients should be instructed to notify their physicians promptly if they experience any of the following: fever, loss of appetite, malaise, nausea and vomiting, darkened urine, yellowish discoloration of the skin and eyes, and pain or swelling of the joints. Compliance with the full course of therapy must be emphasized, and the importance of not missing any doses must be stressed.
